ABO/Rh Typing: Forward, Reverse, and Discrepancies
Key Takeaways
- ABO interpretation requires agreement between forward typing on patient red cells and reverse typing on patient plasma or serum.
- The safest exam answer for an unresolved ABO discrepancy is to stop final interpretation, check identity/history, repeat or investigate, and avoid ABO-specific release until resolved.
- Extra reverse reactions often point to cold-reactive antibodies or rouleaux; weak reverse reactions often point to age, immunosuppression, hypogammaglobulinemia, or recent transfusion history.
- Weak D handling is role dependent: donors with confirmed weak D are labeled Rh positive, while recipients with uncertain D status are protected according to policy, often as Rh negative.
- Emergency transfusion decisions prioritize immediate patient safety: group O red cells and group AB plasma are the classic unknown-type defaults while testing continues.
Why ABO/Rh typing is high-yield
Blood Banking is 15-20% of the ASCP MLT examination, and ABO/Rh typing sits at the front of nearly every transfusion decision. On the exam, the question often gives a reaction table and asks for the interpretation, the source of a discrepancy, or the first safe action. The core rule is simple: do not treat a single column as the answer. ABO typing is a two-part conclusion.
Forward typing tests the patient's red cells with known antisera, usually anti-A and anti-B. It asks which ABO antigens are on the cells. Reverse typing tests the patient's plasma or serum with known reagent A1 and B cells. It asks which expected ABO antibodies are present.
| ABO group | Forward anti-A | Forward anti-B | Reverse A1 cells | Reverse B cells | Expected plasma antibodies |
|---|---|---|---|---|---|
| A | Positive | Negative | Negative | Positive | Anti-B |
| B | Negative | Positive | Positive | Negative | Anti-A |
| AB | Positive | Positive | Negative | Negative | None expected |
| O | Negative | Negative | Positive | Positive | Anti-A and anti-B |
For routine adult specimens, forward and reverse typing should support the same ABO group. If they do not, the MLT exam usually rewards a safety-first answer: verify specimen and patient identification, repeat the questionable test, review history, and resolve the discrepancy before issuing type-specific red cells or plasma.
Discrepancy patterns to recognize
ABO discrepancies become easier if you classify the unexpected result before choosing the next step.
| Pattern | Common exam clues | First decision pattern |
|---|---|---|
| Weak or missing forward reaction | Newborn, weak subgroup, leukemia, transplant, recent transfusion, technical error | Repeat, check cell suspension and reagent, review history, consider additional antisera or adsorption/elution by policy |
| Extra forward reaction | Mixed-field agglutination, recent group O transfusion into group A patient, stem cell transplant, acquired B phenomenon | Review transfusion/transplant history and do not overcall a new ABO type from mixed cells |
| Weak or missing reverse reaction | Newborn, elderly patient, immunocompromised patient, hypogammaglobulinemia, recent plasma exchange | Incubate/enhance reverse grouping if allowed and interpret with age/history |
| Extra reverse reaction | Cold autoantibody, cold alloantibody such as anti-M, anti-P1, anti-Lea, anti-A1, rouleaux | Check autocontrol, prewarm if indicated, saline replacement for rouleaux, identify antibody if clinically relevant |
The first action is not always the most sophisticated antibody workup. For an MLT-level item, the first action is often clerical and interpretive: does this specimen belong to this patient, was the correct reagent used, and does the patient's age or recent transfusion explain the pattern?
High-yield discrepancy examples
A group A patient should react with anti-A and should have anti-B in reverse typing. If the reverse A1 cell is unexpectedly positive while the B cell is also positive, think about an extra reverse reaction, especially anti-A1 in an A subgroup or a cold antibody. You still do not finalize the ABO type until the discrepancy is resolved.
A newborn may show forward A or B antigen but little or no reverse antibody because infants have not produced expected ABO isoagglutinins. An elderly or immunosuppressed patient may show the same weak reverse pattern. That is different from a technical failure, so the exam expects you to use history.
Mixed-field forward reactions matter because recently transfused donor red cells can appear in the patient's sample. A group A patient who received emergency group O red cells can show mixed or weakened forward anti-A reactions. A transplant recipient can also show mixed-field patterns as donor and recipient hematopoiesis change.
Rouleaux can mimic agglutination in reverse grouping. A clue is a patient with markedly increased proteins, such as plasma cell dyscrasia. Saline replacement disperses rouleaux but not true antigen-antibody agglutination.
Rh typing decision points
Rh typing usually refers to D antigen testing. A clear anti-D reaction means the red cells are D positive. No reaction means D negative unless weak D testing or policy changes the interpretation. For exam purposes, separate donors from recipients.
| Scenario | Exam-safe interpretation |
|---|---|
| Donor immediate-spin D negative, weak D positive at antiglobulin phase | Label donor unit Rh positive |
| Recipient initially D negative with uncertain or weak D status | Protect recipient according to policy, commonly with Rh-negative red cells until resolved |
| Rh-negative pregnant patient, antibody screen negative at 28 weeks | Candidate for Rh immune globulin prophylaxis |
| Rh-negative mother delivers D-positive or weak D-positive infant | Postpartum Rh immune globulin is indicated if mother is not already alloimmunized |
The reason is risk direction. A weak D donor unit could immunize a truly D-negative recipient, so it is labeled Rh positive. A recipient with uncertain D status should not be exposed casually to D-positive red cells if Rh-negative inventory is available and policy requires protection.
Emergency compatibility frame
When ABO/Rh is unresolved and blood is needed immediately, transfusion service policy and provider authorization control release. The exam pattern is consistent: do not force a final ABO type from an unresolved discrepancy. Use emergency-release workflow, continue testing, document the risk acceptance, and switch to type-specific compatible components only when safe.
The classic unknown-type defaults are group O red cells and group AB plasma. Rh-negative red cells are preferred for females of childbearing potential when inventory allows because anti-D can cause hemolytic disease of the fetus and newborn in a future pregnancy. In massive hemorrhage, inventory stewardship may require policy-based Rh-positive use for selected males or older females, but the first exam answer is still to protect patients at highest alloimmunization risk.
Forward grouping is anti-A 4+, anti-B 0. Reverse grouping is A1 cells 1+, B cells 4+, and the autocontrol is negative. Which is the best first interpretation?
A 2-month-old infant has forward anti-A 3+, anti-B 0, but reverse A1 cells 0 and B cells 0. What explanation best fits the pattern?
A donor unit is D negative at immediate spin but weak D positive at the antiglobulin phase. How should the donor Rh type be handled?